456 Studies Now Enrolling
Study of Web-based Decision Aids for Breast Cancer Risk Assessment and Increasing Breast Cancer Chemoprevention in the Primary Care Setting: Pilot & RCT
Breast Cancer Prevention Study of Web-based Decision Aids for Increasing Breast Cancer Chemoprevention in the Primary Care Setting
| Sponsor: | National Cancer Institute |
| Enrolling: | Female Patients Only |
| IRB Number: | AAAP4151 |
| U.S. Govt. ID: | NCT03069742 |
| Contact: | Katherine Crew: 212-305-5098 / kd59@cumc.columbia.edu |
Additional Study Information:
The purpose of this randomized controlled trial (RCT) is to evaluate a decision support website (RealRisks) designed to inform patients about breast cancer prevention options. It is coupled with a physician-centered (BNAV) decision support website as part of clinical workflow in the primary care setting. The investigators hypothesize that improving accuracy of breast cancer risk perception and understanding of the risks and benefits of breast cancer risk lowering drugs, also known as chemoprevention, will increase the uptake of chemoprevention in the primary care setting.Before beginning the study we will first complete a brief screening interview to determine whether you are eligible to participate.
This study is closed
Do You Qualify?
| Are you between 35-75 years of age? | Yes | No |
| Have you ever used anti-estrogen pills to lower breast cancer risk? | Yes | No |
| Do you have a personal history of breast cancer? | Yes | No |
| Do you have a primary care provider at Columbia University Medical Center / NewYork-Presbyterian Hospital? | Yes | No |
| Do you have an active cancer diagnosis? | Yes | No |